SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

77,966.35 -187.90
( -0.24%)

Global Indices

Nasdaq

53,805.64 -191.34
(-0.35%)

Dow Jones

7,747.95 -26.16
(-0.34%)

Hang Seng

67,546.56 576.34
(0.86%)

Nikkei 225

10,849.18 -13.32
(-0.12%)

Forex

USD-INR

95.28 0.13
(0.14%)

EUR-INR

110.05 0.08
(0.07%)

GBP-INR

128.64 0.30
(0.23%)

JPY-INR

0.60 0.00
(-0.45%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Concord Biotech Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

543960

INE338H01029

193.0629905

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CONCORDBIO

52.63

14963.78

EPS(TTM)

Face Value()

Div & Yield %

27.18

0.53

Back

Indo National reports standalone net loss of Rs 6.62 crore in the December 2025 quarter

Feb 04,2026

Net loss of Indo National reported to Rs 6.62 crore in the quarter ended December 2025 as against net profit of Rs 0.63 crore during the previous quarter ended December 2024. Sales declined 12.76% to Rs 106.11 crore in the quarter ended December 2025 as against Rs 121.63 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	106.11	121.63	-13
OPM %	-4.92	1.23	-
PBDT	-3.93	3.17	PL
PBT	-7.23	0.27	PL
NP	-6.62	0.63	PL

77,966.35 -187.90 ( -0.24%)

53,805.64 -191.34 (-0.35%)

7,747.95 -26.16 (-0.34%)

67,546.56 576.34 (0.86%)

10,849.18 -13.32 (-0.12%)

95.28 0.13 (0.14%)

110.05 0.08 (0.07%)

128.64 0.30 (0.23%)

0.60 0.00 (-0.45%)